KFDA to map out guideline over microdose study

The Korea and Drug Food Administration said it will draw up a new guideline on microdose clinical trials as part of efforts to improve the critical development path tha leads from scientific discovery to the patient.

In this scenario, Phase 0 (zero) trials may allow an eary evaluation in humans of pharmacokinetic and pharmocodynamic profiles of test compounds through administration of sub-ph...